We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.36%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.26B
AUM Growth
+$299M
(+15%)
Cap. Flow
+$214M
Cap. Flow
% of AUM
9.45%
Top 10 Holdings %
Top 10 Hldgs %
6.6%
Holding
1,916
New
614
Increased
388
Reduced
316
Closed
591
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$16.7M |
| 2 |
Netflix
NFLX
|
+$14.1M |
| 3 |
US Bancorp
USB
|
+$12.4M |
| 4 |
GE Aerospace
GE
|
+$11.7M |
| 5 |
Charter Communications
CHTR
|
+$11.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$23M |
| 2 |
AbbVie
ABBV
|
+$18.8M |
| 3 |
Intuit
INTU
|
+$13.1M |
| 4 |
Texas Instruments
TXN
|
+$12.6M |
| 5 |
Booking.com
BKNG
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.57% |
| 2 | Industrials | 13.56% |
| 3 | Technology | 13.35% |
| 4 | Healthcare | 13.31% |
| 5 | Financials | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDSI
976
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $401K | 0.02% |
136,155
+64,700
| +91% | +$179K |
|
977
ING
ING
$95.7B
| $400K | 0.02% |
21,700
-106,800
| -83% | -$1.96M |
|
978
MillerKnoll
MLKN
$1.54B
| $400K | 0.02% |
+9,999
| New | +$351K |
|
|
SHLO
979
DELISTED
Shiloh Industries Inc
SHLO
| $400K | 0.02% |
48,800
+16,300
| +50% | +$148K |
|
|
EVRI
980
DELISTED
Everi Holdings
EVRI
| $399K | 0.02% |
52,959
-7,800
| -13% | -$62.9K |
|
981
The Mosaic Company
MOS
$7.1B
| $397K | 0.02% |
15,500
-19,000
| -55% | -$437K |
|
982
StoneX
SNEX
$9B
| $395K | 0.02% |
47,122
-12,150
| -20% | -$99.9K |
|
|
USAK
983
DELISTED
USA Truck Inc
USAK
| $394K | 0.02% |
+21,774
| New | +$352K |
|
984
Centene
CNC
$31.6B
| $393K | 0.02% |
7,800
-31,000
| -80% | -$1.5M |
|
|
SRG
985
Seritage Growth Properties
SRG
$133M
| $393K | 0.02% |
+9,719
| New | +$406K |
|
|
SHYF
986
DELISTED
The Shyft Group
SHYF
| $392K | 0.02% |
+24,889
| New | +$378K |
|
987
Werner Enterprises
WERN
$2.42B
| $390K | 0.02% |
10,091
+2,034
| +25% | +$73.9K |
|
988
Bio-Techne
TECH
$11.2B
| $388K | 0.02% |
+12,000
| New | +$381K |
|
|
LKSD
989
DELISTED
LSC Communications, Inc.
LKSD
| $388K | 0.02% |
+25,661
| New | +$408K |
|
990
First Busey Corp
BUSE
$2.52B
| $386K | 0.02% |
+12,900
| New | +$401K |
|
991
Citizens Financial Group
CFG
$30.1B
| $386K | 0.02% |
9,200
-54,300
| -86% | -$2.12M |
|
992
Kinsale Capital Group
KNSL
$8.24B
| $386K | 0.02% |
+8,591
| New | +$374K |
|
993
Bank of Montreal
BMO
$125B
| $384K | 0.02% |
4,800
-7,700
| -62% | -$600K |
|
|
ACHN
994
DELISTED
Achillion Pharmaceuticals
ACHN
| $383K | 0.02% |
133,113
+50,400
| +61% | +$183K |
|
995
Conduent
CNDT
$234M
| $382K | 0.02% |
+23,700
| New | +$371K |
|
996
Hilton Grand Vacations
HGV
$3.98B
| $381K | 0.02% |
+9,100
| New | +$370K |
|
997
Caesarstone
CSTE
$75.7M
| $379K | 0.02% |
17,242
-2,187
| -11% | -$56.1K |
|
998
Vermilion Energy
VET
$1.62B
| $379K | 0.02% |
+10,436
| New | +$364K |
|
999
Pacira BioSciences
PCRX
$1.04B
| $378K | 0.02% |
+8,300
| New | +$329K |
|
|
ATRS
1000
DELISTED
Antares Pharma, Inc.
ATRS
| $377K | 0.02% |
189,627
+175,613
| +1,253% | +$382K |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, A.R.T. Advisors held 1,916 positions worth $2.26B, up 15% from $1.96B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.
A.R.T. Advisors deployed $214M of net new capital in Q4 2017, opening 614 new positions and adding to 388 existing holdings. Its largest new stake was IBM: 114,615 shares worth $16.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was AbbVie, an estimated $18.8M trimmed.
- A.R.T. Advisors's largest Q4 2017 buy was IBM: 114,615 shares worth $16.8M.
- A.R.T. Advisors added most to Netflix in Q4 2017, an estimated $14.1M increase.
- A.R.T. Advisors's biggest Q4 2017 reduction was AbbVie, cutting an estimated $18.8M.
- A.R.T. Advisors fully exited Celgene Corp in Q4 2017, selling an estimated $23M.
- A.R.T. Advisors's ten largest holdings make up 6.6% of its $2.26B portfolio in Q4 2017.
- A.R.T. Advisors opened 614 new positions and closed 591 in Q4 2017.
- A.R.T. Advisors's portfolio value rose 15% quarter-over-quarter to $2.26B.
Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.